The PEP++ study protocol: a cluster-randomised controlled trial on the effectiveness of an enhanced regimen of post-exposure prophylaxis for close contacts of persons affected by leprosy to prevent disease transmission

The PEP++ study protocol: a cluster-randomised controlled trial on the effectiveness of an enhanced regimen of post-exposure prophylaxis for close contacts of persons affected by leprosy to prevent disease transmission

Abstract Background Leprosy is an infectious disease with a slow decline in global annual caseload in the past two decades. Active case finding and post-exposure prophylaxis (PEP) with a single dose of rifampicin (SDR) are recommended by the World Health Organization as measures for leprosy eliminat...

Full description

Bibliographic Details
Main Authors: Duane C. Hinders, Anneke T. Taal, Suchitra Lisam, Aymée M. da Rocha, Nand Lal Banstola, Prativa Bhandari, Abhijit Saha, Jugal Kishore, Virginia O. Fernandes, Abu Sufian Chowdhury, Anna T. van ‘t Noordende, Liesbeth Mieras, Jan Hendrik Richardus, Wim H. van Brakel
Format: Article
Language:English
Published: BMC 2024-02-01
Series:BMC Infectious Diseases
Subjects:
Leprosy
Post-exposure prophylaxis
Rifampicin
Clarithromycin
Blanket campaigns
High-endemic areas
Online Access:https://doi.org/10.1186/s12879-024-09125-2

Internet

https://doi.org/10.1186/s12879-024-09125-2

Similar Items